---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-000422"
form_type: "8-K"
ticker: "DERM"
cik: "0001867066"
company_name: "Journey Medical Corp"
filed_at: "2023-01-03T23:59:59+00:00"
generated_at: "2026-06-20T21:04:25.896227+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Journey Medical enters ATM sales agreement with B. Riley for up to 4.9M shares

## Summary
- Company may offer and sell up to 4,900,000 shares of common stock through Agent B. Riley Securities in at-the-market offerings.
- Sales require effectiveness of new S-3 registration statement filed December 30, 2022; Agent commission is 3.0% of gross proceeds.
- Company is not obligated to sell any shares; agreement continues until all shares sold or terminated by either party.
- Customary indemnification and expense reimbursement provided to Agent; offering may be conducted with price, time, or size limits.

## SEC filing metadata
- accession: 0001104659-23-000422
- form_type: 8-K
- ticker: DERM
- cik: 0001867066
- company_name: Journey Medical Corp
- filed_at: 2023-01-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867066/000110465923000422/0001104659-23-000422-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867066/000110465923000422/tm231431d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-000422
- JSON: https://secwatch.observer/filing/0001104659-23-000422.json
- Plain text: https://secwatch.observer/filing/0001104659-23-000422.txt

## Key facts
- Material Agreements
  Journey Medical Corp entered into At Market Issuance Sales Agreement with B. Riley Securities, Inc. valued at Agreement for the issuance and sale of up to 4,900,000 shares of common stock through agent at marke (effective 2022-12-30).
  - Action: entry
  - Agreement: atm program
  - Counterparty: B. Riley Securities, Inc.
  - Value: Agreement for the issuance and sale of up to 4,900,000 shares of common stock through agent at marke
  - Effective: 2022-12-30
  source text: On December 30, 2022, Journey Medical Corporation (the “Company”) entered into an At Market Issuance Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Agent”), under which the Company may offer and sell, from time to time at its sole discretion, 4,900,000 shares of its common stock, par value $0.0001 per share (the “Shares”), through or to the Agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1867066/000110465923000422/0001104659-23-000422-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.